Ziextenzo and Nausea and vomiting - a phase IV clinical study of FDA data

Summary:

Nausea and vomiting is reported as a side effect among people who take Ziextenzo (pegfilgrastim-bmez), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Dexamethasone, and have Dyspnea.

The phase IV clinical study analyzes which people have Nausea and vomiting when taking Ziextenzo. It is created by eHealthMe based on reports of 507 people who have side effects when taking Ziextenzo from the FDA, and is updated regularly.

What is Ziextenzo?

Ziextenzo has active ingredients of pegfilgrastim-bmez. eHealthMe is studying from 508 Ziextenzo users. Check the latest studies of Ziextenzo.

What is Nausea and vomiting?

Nausea and vomiting is found to be associated with 3,701 drugs and 5,744 conditions by eHealthMe. Check the latest studies of Nausea and vomiting.

On Jul, 18, 2026

507 people reported to have side effects when taking Ziextenzo.
Among them, 18 people (3.55%) have Nausea and vomiting.

Could Ziextenzo cause Nausea and vomiting?

Among these 18 people:

How long have people been on Ziextenzo when they have Nausea and vomiting? *

What is the gender of people who have Nausea and vomiting when taking Ziextenzo? *

female: 72.22 %
male: 27.78 %

What is the age of people who have Nausea and vomiting when taking Ziextenzo? *

What are other drugs people take besides Ziextenzo? *

What are other side effects people have besides Nausea and vomiting? *

Dyspnea (difficult or laboured breathing): 9 people, 50.00%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 8 people, 44.44%
Fatigue (feeling of tiredness): 6 people, 33.33%
Diarrhea: 5 people, 27.78%
Nausea (feeling of having an urge to vomit): 3 people, 16.67%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 2 people, 11.11%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 2 people, 11.11%
Fainting (loss of consciousness and postural tone): 2 people, 11.11%
Dizziness: 2 people, 11.11%
Septic Shock (shock due to blood infection): 2 people, 11.11%

What are the existing conditions these people have? *

Dyspnea (difficult or laboured breathing): 8 people, 44.44%
Gout (uric acid crystals building up in the body): 7 people, 38.89%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 38.89%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 7 people, 38.89%
High Blood Pressure: 7 people, 38.89%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 38.89%
Left Ventricular Failure (left ventricle fails to contract forcefully): 7 people, 38.89%
Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 2 people, 11.11%
Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 2 people, 11.11%
Lung Neoplasm (tumour of lung): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Ziextenzo and have Nausea and vomiting?

- Check whether Nausea and vomiting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ziextenzo:

Ziextenzo (508 reports)

Browse all side effects of Ziextenzo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nausea and vomiting:

Nausea and vomiting (3,701 drugs)

Browse all the conditions that are associated with Nausea and vomiting:

Nausea and vomiting (5,744 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pegfilgrastim-bmez (the active ingredients of Ziextenzo) and Ziextenzo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.